1. After the treatment of 64 patients suffering
from chronic benign tertian malaria 53.1 per cent.
relapsed as compared with 40 per cent. amongst control
cases treated with plasmoquine, plasmoquine compound
2.uinine troposan rapidly removes all forms of
Pl. vivax from the peripheral blood.
3. In the doses given in these trials quinine
troposan had no toxic effects.
4. The effect of quinine troposan in reducing the
spleen is almost equal to that of quinine.
5. 60 per cent. of she cases treated with quinine
troposan gained weight as compared with 50 per cent. ma
amongst control cases treated with. quinine.
6. 69 per cent. of the cases treated with quinine
troposan showed an increase of haemoglobin as compared
with 71 per cent, amongst control cases treated with
As the result of this research it is considered that
the best treatment for chronic benign tertian malaria is
a continuous one as follows
(a). Treatment recommended for disciplined bodies
(b). Treatment recommended for the general populus.
(a). Plasmo4uine combined with quinine is undoubtedly the best treatment for disciplined bodies of people
such of those of armies, ships, institutes and hospitals
where the dosage can be regulated according to the idiosyncracy of the patient to toxic symptoms.
The dose of plasmoquine tested, namely 0.08 grms.,
combined with 20 grains (1.3 grms.) of quinine is the
treatment of choice, and should be continued for 28 days.
(b). The general populus must still continue to be
treated with quinine and tonic treatment, namely 30
grains (1.94 grins.) of quinine daily for 14 days followed
by 10 grains daily given with iron and arsenic tonic for